全文获取类型
收费全文 | 188163篇 |
免费 | 5003篇 |
国内免费 | 172篇 |
专业分类
耳鼻咽喉 | 4858篇 |
儿科学 | 6829篇 |
妇产科学 | 7337篇 |
基础医学 | 32012篇 |
口腔科学 | 3896篇 |
临床医学 | 12931篇 |
内科学 | 37805篇 |
皮肤病学 | 6975篇 |
神经病学 | 14406篇 |
特种医学 | 6890篇 |
外国民族医学 | 38篇 |
外科学 | 26880篇 |
综合类 | 986篇 |
一般理论 | 103篇 |
预防医学 | 11852篇 |
眼科学 | 6207篇 |
药学 | 7213篇 |
中国医学 | 132篇 |
肿瘤学 | 5988篇 |
出版年
2021年 | 1614篇 |
2019年 | 1478篇 |
2018年 | 1869篇 |
2017年 | 1391篇 |
2016年 | 1530篇 |
2015年 | 4697篇 |
2014年 | 5844篇 |
2013年 | 7971篇 |
2012年 | 7767篇 |
2011年 | 7655篇 |
2010年 | 6083篇 |
2009年 | 5877篇 |
2008年 | 7262篇 |
2007年 | 7103篇 |
2006年 | 7280篇 |
2005年 | 6700篇 |
2004年 | 6103篇 |
2003年 | 4202篇 |
2002年 | 2742篇 |
1999年 | 1225篇 |
1998年 | 1640篇 |
1997年 | 1540篇 |
1996年 | 1892篇 |
1995年 | 2071篇 |
1994年 | 2070篇 |
1993年 | 1927篇 |
1992年 | 1945篇 |
1991年 | 1692篇 |
1990年 | 1526篇 |
1989年 | 1356篇 |
1988年 | 1246篇 |
1987年 | 1293篇 |
1986年 | 1255篇 |
1985年 | 1089篇 |
1984年 | 1204篇 |
1982年 | 1219篇 |
1981年 | 1160篇 |
1978年 | 1206篇 |
1933年 | 1501篇 |
1932年 | 1489篇 |
1931年 | 1475篇 |
1930年 | 1657篇 |
1929年 | 1393篇 |
1928年 | 1537篇 |
1927年 | 1498篇 |
1926年 | 1583篇 |
1925年 | 1544篇 |
1924年 | 1612篇 |
1923年 | 1471篇 |
1922年 | 1445篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
61.
Béla Nagy Zsolt Bene Zsolt Fejes Sonya L. Heltshe David Reid Nicola J. Ronan Yvonne McCarthy Daniel Smith Attila Nagy Elizabeth Joseloff György Balla János Kappelmayer Milan Macek Scott C. Bell Barry J. Plant Margarida D. Amaral István Balogh 《Journal of cystic fibrosis》2019,18(2):271-277
Background
We have recently shown that human epididymis protein 4 (HE4) levels correlate with the severity of cystic fibrosis (CF) lung disease. However, there are no data on how HE4 levels alter in patients receiving CFTR modulating therapy.Methods
In this retrospective clinical study, 3 independent CF patient cohorts (US-American: 29, Australian: 12 and Irish: 19 cases) were enrolled carrying at least one Class III CFTR CF-causing mutation (p.Gly551Asp) and being treated with CFTR potentiator ivacaftor. Plasma HE4 was measured by immunoassay before treatment (baseline) and 1–6?months after commencement of ivacaftor, and were correlated with FEV1 (% predicted), sweat chloride, C-reactive protein (CRP) and body mass index (BMI).Results
After 1?month of therapy, HE4 levels were significantly lower than at baseline and remained decreased up to 6?months. A significant inverse correlation between absolute and delta values of HE4 and FEV1 (r?=??0.5376; P?<?.001 and r?=??0.3285; P?<?.001), was retrospectively observed in pooled groups, including an independent association of HE4 with FEV1 by multiple regression analysis (β?=??0.57, P?=?.019). Substantial area under the receiver operating characteristic curve (ROC-AUC) value was determined for HE4 when 7% mean change of FEV1 (0.722 [95% CI 0.581–0.863]; P?=?.029) were used as classifier, especially in the first 2?months of treatment (0.806 [95% CI 0.665–0.947]; P?<?.001).Conclusions
This study shows that plasma HE4 levels inversely correlate with lung function improvement in CF patients receiving ivacaftor. Overall, this potential biomarker may be of value for routine clinical and laboratory follow-up of CFTR modulating therapy. 相似文献62.
63.
Lars J Vatten Tom I L Nilsen P?l R Romundstad Wenche B Dr?yvold Jostein Holmen 《European journal of cardiovascular prevention and rehabilitation》2006,13(6):909-915
OBJECTIVE: To investigate whether cardiovascular mortality related to obesity could be modified by physical activity. DESIGN: Mortality follow-up. SETTING: Population study. PARTICIPANTS: Participants in a health survey: 34 868 women and 32 872 men free from known cardiovascular disease or diabetes at baseline. MAIN OUTCOME MEASURES: Total cardiovascular mortality. MAIN RESULTS: During 16 years of follow-up, 3026 women and 3526 men had died from cardiovascular causes. In middle age, obesity [body mass index (BMI) of 30 or higher] was associated with increased risk of cardiovascular death, but the association weakened with age. After 70, there was no association between BMI and cardiovascular death. At all ages, a lower level of physical activity was associated with a higher cardiovascular mortality. In women with high physical activity, indicated by at least 30 min of moderate to vigorous activity more than once a week, cardiovascular mortality was only slightly higher in the obese compared to lean women (adjusted relative risk, 1.27; 95% confidence interval, 0.80-2.00). In men with high physical activity, cardiovascular mortality was, however, significantly higher among the obese (relative risk, 1.62; 95% confidence interval, 1.09-2.40). In both genders cardiovascular mortality was substantially higher in obese people who reported no regular physical activity compared to obese people with a high level of physical activity. CONCLUSION: In obese women, being highly active may, to a large extent, compensate for the risk-increasing effect of being obese, whereas in obese men who engage in a high level of physical activity, the risk of cardiovascular death may be higher than in lean and equally active men. 相似文献
64.
T. Kapellen A. Galler K. Claus S. Heger D. Härtig Prof. Dr. W. Kiess 《Der Diabetologe》2006,2(2):167-181
Type 1 diabetes is one of the commonest chronic disorders encountered in children and adolescents. When it first becomes apparent in children, approximately 20% of them have clinical and biochemical signs of ketoacidosis (DKA). In the presence of unusual clinical symptoms it is necessary to consider the possibility of associated conditions, such as coeliac disease, immunothyroiditis and Addison’s disease. Children with diabetes must be treated by a multidisciplinary team made up of paediatrician, paediatric diabetes specialist, psychologist, social worker, ophthalmologist, dietitian, nurse and diabetes counsellor, making it essential for them to be treated in regional specialised centres. They are treated in their own psychosocial environment and their families are involved in the therapy. Comprehensive, multidisciplinary treatment strategies have now made it possible for these patients to enjoy normal physical wellbeing and near-normal psychosocial development. Prevention and early treatment of of disturbances associated with diabetes remain an important concern. The fact that type 2 diabetes must now be looked for in overweight children and adolescents is a new aspect of diabetes medicine. 相似文献
65.
Chronic transplant dysfunction is a complex dynamic pathogenic process. Clinically, a decrease in glomerular filtration rate (GFR) becomes apparent leading to chronic renal insufficiency and dialysis or death from cardiovascular events. Chronic transplant dysfunction can develop into a chronic alIograft nephropathy (CAN) as a specific entity with dynamic progression. CAN includes a collection of immunologic and non-immunologic factors, rejection, ischemia time, donor and recipient characteristics and toxicity of calcineurin inhibitors. Despite improvements in immunosuppression, the long-range prognosis of renal allografts has not improved. Whether modern immunosuppressive concepts with reduction or avoidance of calcineurin inhibitors and a therapy based on antimetabolites, such as mycophenolate or mTOR-inhibitors could lead to a prolongation of transplant survival, remains to be seen. 相似文献
66.
67.
68.
Dr. med. Dr. Univ. Rom A. Zeyfang 《Der Diabetologe》2006,2(3):262-274
Zusammenfassung In Deutschland leiden 25% der über 70-Jährigen unter einem Diabetes mellitus. Biologisch ältere, multimorbide und in ihren Funktionen beeinträchtigte geriatrische Patienten benötigen spezielle Vorgehensweisen bei Zielplanung, Allgemeinmaßnahmen und Pharmakotherapie. Auf der Basis der vorhandenen Leitlinien werden gesicherte Erkenntnisse dargestellt und Empfehlungen zu den Besonderheiten der Therapie des geriatrischen Diabetespatienten gegeben. Besonderes Augenmerk liegt dabei auf der Interaktion von geriatrischen Syndromen und Diabetes sowie der Verbesserung der Lebensqualität. 相似文献
69.
70.